Envoy Medical (COCH) Non Operating Income (2021 - 2026)

Envoy Medical (COCH) has 6 years of Non Operating Income data on file, last reported at $1.6 million in Q1 2026.

• For the quarter ending Q1 2026, Non Operating Income rose 1375.23% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $13000.0 (up 130.23% YoY), and the FY2025 full-year result was -$1.5 million, up 3.44% from the prior year.
• Non Operating Income advanced to $1.6 million in Q1 2026, from -$201000.0 in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $4.9 million in Q3 2023 to a low of -$9.5 million in Q1 2023.
• A 5-year average of -$1.4 million and a median of -$201000.0 in 2025 frame the typical range for Non Operating Income.
• Across the five-year window, Non Operating Income slumped 191.3% in 2025 and surged 1375.23% in 2026, its largest moves.
• Tracing COCH's Non Operating Income over 5 years: stood at -$8.6 million in 2022, then surged by 121.33% to $1.8 million in 2023, then plunged by 103.77% to -$69000.0 in 2024, then tumbled by 191.3% to -$201000.0 in 2025, then surged by 900.0% to $1.6 million in 2026.
• Business Quant data shows COCH's Non Operating Income at $1.6 million in Q1 2026, -$201000.0 in Q4 2025, and -$774000.0 in Q3 2025.